Cargando…

COVID-19 Disease and Vitamin D: A Mini-Review

Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulkrane, Mohamed Said, Ilina, Victoria, Melchakov, Roman, Fedotova, Julia, Drago, Filippo, Gozzo, Lucia, Das, Undurti Narasimha, Abd El-Aty, A. M., Baranenko, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773655/
https://www.ncbi.nlm.nih.gov/pubmed/33390994
http://dx.doi.org/10.3389/fphar.2020.604579
_version_ 1783630090621419520
author Boulkrane, Mohamed Said
Ilina, Victoria
Melchakov, Roman
Fedotova, Julia
Drago, Filippo
Gozzo, Lucia
Das, Undurti Narasimha
Abd El-Aty, A. M.
Baranenko, Denis
author_facet Boulkrane, Mohamed Said
Ilina, Victoria
Melchakov, Roman
Fedotova, Julia
Drago, Filippo
Gozzo, Lucia
Das, Undurti Narasimha
Abd El-Aty, A. M.
Baranenko, Denis
author_sort Boulkrane, Mohamed Said
collection PubMed
description Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.
format Online
Article
Text
id pubmed-7773655
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77736552021-01-01 COVID-19 Disease and Vitamin D: A Mini-Review Boulkrane, Mohamed Said Ilina, Victoria Melchakov, Roman Fedotova, Julia Drago, Filippo Gozzo, Lucia Das, Undurti Narasimha Abd El-Aty, A. M. Baranenko, Denis Front Pharmacol Pharmacology Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773655/ /pubmed/33390994 http://dx.doi.org/10.3389/fphar.2020.604579 Text en Copyright © 2020 Boulkrane, Ilina, Melchakov, Fedotova, Drago, Gozzo, Das, Abd El-Aty and Baranenko http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Boulkrane, Mohamed Said
Ilina, Victoria
Melchakov, Roman
Fedotova, Julia
Drago, Filippo
Gozzo, Lucia
Das, Undurti Narasimha
Abd El-Aty, A. M.
Baranenko, Denis
COVID-19 Disease and Vitamin D: A Mini-Review
title COVID-19 Disease and Vitamin D: A Mini-Review
title_full COVID-19 Disease and Vitamin D: A Mini-Review
title_fullStr COVID-19 Disease and Vitamin D: A Mini-Review
title_full_unstemmed COVID-19 Disease and Vitamin D: A Mini-Review
title_short COVID-19 Disease and Vitamin D: A Mini-Review
title_sort covid-19 disease and vitamin d: a mini-review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773655/
https://www.ncbi.nlm.nih.gov/pubmed/33390994
http://dx.doi.org/10.3389/fphar.2020.604579
work_keys_str_mv AT boulkranemohamedsaid covid19diseaseandvitamindaminireview
AT ilinavictoria covid19diseaseandvitamindaminireview
AT melchakovroman covid19diseaseandvitamindaminireview
AT fedotovajulia covid19diseaseandvitamindaminireview
AT dragofilippo covid19diseaseandvitamindaminireview
AT gozzolucia covid19diseaseandvitamindaminireview
AT dasundurtinarasimha covid19diseaseandvitamindaminireview
AT abdelatyam covid19diseaseandvitamindaminireview
AT baranenkodenis covid19diseaseandvitamindaminireview